These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15768345

  • 1. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Litwin AH, Soloway I, Gourevitch MN.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S339-45. PubMed ID: 15768345
    [Abstract] [Full Text] [Related]

  • 2. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
    Int J Drug Policy; 2007 Oct 15; 18(5):417-25. PubMed ID: 17854731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treating hepatitis C virus infection in active substance users.
    Sylvestre DL.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S321-4. PubMed ID: 15768341
    [Abstract] [Full Text] [Related]

  • 5. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W, Stanley J, Langton D, Kelly Y, Bury G.
    Eur J Gen Pract; 2007 Apr 15; 13(1):5-12. PubMed ID: 17366287
    [Abstract] [Full Text] [Related]

  • 6. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A, Treloar C, Dore GJ.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R, Byrne A, Amin J, Dore GJ.
    J Gastroenterol Hepatol; 2005 Jul 15; 20(7):1082-6. PubMed ID: 15955218
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.
    Backmund M, Reimer J, Meyer K, Gerlach JT, Zachoval R.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S330-5. PubMed ID: 15768343
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.
    Zeiler I, Langlands T, Murray JM, Ritter A.
    Drug Alcohol Depend; 2010 Aug 01; 110(3):228-33. PubMed ID: 20430537
    [Abstract] [Full Text] [Related]

  • 14. Integrating HCV services for drug users: a model to improve engagement and outcomes.
    Sylvestre DL, Zweben JE.
    Int J Drug Policy; 2007 Oct 01; 18(5):406-10. PubMed ID: 17854729
    [Abstract] [Full Text] [Related]

  • 15. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY, White MC, Kushel MB, Song YS, Tulsky JP.
    J Subst Abuse Treat; 2005 Mar 01; 28(2):181-7. PubMed ID: 15780548
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.
    Sulkowski MS, Thomas DL.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S263-9. PubMed ID: 15768333
    [Abstract] [Full Text] [Related]

  • 17. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G, Kronborg IJ, Dore GJ.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection.
    Hagan H, Strauss SM, Astone JM, Des Jarlais DC.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S297-303. PubMed ID: 15768338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.